Editorial · 28 May 2025
Conference abstractPublished 2016
Biomarker development for allergic risk assessment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
There is an increase in the incidence of allergy/immunotoxicity-related post-market adverse events associated with medical devices. Biomarkers are commonly used in toxicology for risk assessment and clinically as diagnostic and monitoring tests. We developed a new in vitro model where human peripheral blood mononuclear cells (PBMC) serve as immunomodulators for biomarker development specifically for metal related allergenicity. The cell surface proteins were determined quantitatively. One of the purposes is to know whether the biomodulator system is transferable from the dendritic cell (DC) to the PBMC. Out of 12 surface proteins selected from the first tier selection that were screened, we found consistency of BM1 performance between DC and PBMC, and other 3 proteins (BM2, BM3 and BM4) showed promise. The expression of BM1 was downregulated significantly following exposure to three well-known metallic allergens (Cobalt (II) chloride, nickel (II) sulfate, potassium dichromate (VI)), while the expression remained unchanged when exposed to two metallic nonallergens (lead (IV) acetate, magnesium (II) chloride) compared to untreated cells. Data from four healthy donors showed the same pattern. These results indicate that BM1 shows promise for use as a pre-clinical biomarker in screening potential allergenic risks to metalcontaining devices. Further validation is planned.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2016
Biomarker concentration acting as the indicators for chemicals health risk assessment: The case study in Thailand
Case report · 21 May 2022
How Iron Intake and Iron Biomarkers Affect the Risk of Developing Lung Cancer
Conference abstract · 18 Oct 2018
Transcriptomic biomarkers based approach for predicting the risk of heart failure development in postinfarction patients with the use of the ddPCR method
Conference abstract · 2017
Development and validation of risk assessment tool for colorectal cancer screening in North West of Iran
More from this journal
The newest in Oncology & Cancer Case Reports.
Article · 21 Jul 2026
Endocrine sequencing in ESR1-mutant HR+/HER2â?? metastatic breast cancer: a two-case series
Article · 23 Jan 2026
Marked Response after One Cycle of Pembrolizumab Monotherapy for Non-small Cell Lung Cancer: A Case Report and Brief Review of the Literature
Article · 15 Oct 2025
High-Grade Pulmonary Fetal Adenocarcinoma: A Case Report
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOncology & Cancer Case Reports
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ying Mu”
